Evidence map›Paper›PMID 17898871›Full record

ArticleNeoplasia (New York, N.Y.)2007

Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.

Jeannine Missbach-Guentner, Christian Dullin, Marta Zientkowska, Melanie Domeyer-Missbach, Sarah Kimmina, Silvia Obenauer, Fritz Kauer, Walter Stühmer, Eckhardt Grabbe, Wolfgang F Vogel and 1 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Neoplasia (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Micro-CT of rodents: state-of-the-art and future perspectives.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2014
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cancer metastasis as a therapeutic target.European journal of cancer (Oxford, England : 1990) · 2010
    Review
  10. The War on Cancer rages on.Neoplasia (New York, N.Y.) · 2009
    Article
  11. Neoplasia: the second decade.Neoplasia (New York, N.Y.) · 2008
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jeannine Missbach-GuentnerDepartment of Hematology and Oncology, Georg-August-University, Göttingen 37075, Germany. j.missbach@med.uni-goettingen.de
Christian Dullin
Marta Zientkowska
Melanie Domeyer-Missbach
Sarah Kimmina
Silvia Obenauer
Fritz Kauer
Walter Stühmer
Eckhardt Grabbe
Wolfgang F Vogel
Frauke Alves
University of Göttingen · DEMax Planck Institute of Experimental Medicine · DEUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal metastasis is an important cause of mortality in patients with breast cancer. Hence, animal models, in combination with various imaging techniques, are in high demand for preclinical assessment of novel therapies. We evaluated the applicability of flat-panel volume computed tomography (fpVCT) to noninvasive detection of osteolytic bone metastases that develop in severe immunodeficient mice after intracardial injection of MDA-MB-231 breast cancer cells. A single fpVCT scan at 200-microm isotropic resolution was employed to detect osteolysis within the entire skeleton. Osteolytic lesions identified by fpVCT correlated with Faxitron X-ray analysis and were subsequently confirmed by histopathological examination. Isotropic three-dimensional image data sets obtained by fpVCT were the basis for the precise visualization of the extent of the lesion within the cortical bone and for the measurement of bone loss. Furthermore, fpVCT imaging allows continuous monitoring of growth kinetics for each metastatic site and visualization of lesions in more complex regions of the skeleton, such as the skull. Our findings suggest that fpVCT is a powerful tool that can be used to monitor the occurrence and progression of osteolytic lesions in vivo and can be further developed to monitor responses to antimetastatic therapies over the course of the disease.

Indexed as

AdenocarcinomaAnimalsBone NeoplasmsBreast NeoplasmsDisease ProgressionFemaleFemoral NeoplasmsHumerusImaging, Three-DimensionalMiceMice, SCIDModels, AnimalOsteolysisSkull NeoplasmsSpecific Pathogen-Free OrganismsTibiabone metastasisFlat-panel volume computed tomographyin vivo imagingmetastatic breast tumor modelosteolytic lesions

Identifiers

PMID17898871
PMCPMC1993860
OpenAlexW2048474388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.